We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $799M
1-Year Est. Return 253.51%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$427M
AUM Growth
+$26.7M
Cap. Flow
-$898K
Cap. Flow %
-0.21%
Top 10 Hldgs %
94.37%
Holding
21
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CLSD
Clearside Biomedical
CLSD
+$93.9K

Top Sells

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$992K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
1
Protagonist Therapeutics
PTGX
$9.8B
$110M 25.79%
2,449,183
– –
RAPP
2
Rapport Therapeutics
RAPP
$2.27B
$51.2M 11.97%
2,498,051
– –
LEGN icon
3
Legend Biotech
LEGN
$3.93B
$39.7M 9.29%
814,586
– –
CTNM
4
Contineum Therapeutics
CTNM
$576M
$37.9M 8.86%
1,979,173
– –
CVRX icon
5
CVRx
CVRX
$78.3M
$36.2M 8.46%
4,103,430
– –
NBTX
6
Nanobiotix
NBTX
$1.94B
$32.3M 7.57%
5,623,816
– –
PRCT icon
7
Procept Biorobotics
PRCT
$1.26B
$28.7M 6.71%
357,939
– –
MGTX icon
8
MeiraGTx Holdings
MGTX
$1.17B
$27.7M 6.48%
6,641,064
– –
NMRA icon
9
Neumora Therapeutics
NMRA
$321M
$24.4M 5.72%
1,849,445
– –
XNCR icon
10
Xencor
XNCR
$1.71B
$15M 3.52%
748,062
– –
FATE icon
11
Fate Therapeutics
FATE
$294M
$11.8M 2.77%
3,379,064
– –
ARWR icon
12
Arrowhead Research
ARWR
$12.1B
$4.8M 1.12%
247,598
– –
RLYB icon
13
Rallybio
RLYB
$90.1M
$4.25M 1%
454,545
– –
NNOX icon
14
Nano X Imaging
NNOX
$73.2M
$966K 0.23%
158,852
– –
VOR icon
15
Vor Biopharma
VOR
$1.38B
$752K 0.18%
53,733
– –
LAB icon
16
Standard BioTools
LAB
$294M
$602K 0.14%
311,967
– –
ACET icon
17
Adicet Bio
ACET
$77.3M
$525K 0.12%
22,780
– –
PHGE icon
18
BiomX
PHGE
$1.67M
$196K 0.05%
10,122
– –
CLSD
19
DELISTED
Clearside Biomedical
CLSD
$105K 0.02%
+5,499
New +$93.9K
SENS icon
20
Senseonics Holdings Inc
SENS
$409M
$19.1K ﹤0.01%
2,731
– –
ALDX icon
21
Aldeyra Therapeutics
ALDX
$86.9M
– –
-299,669
Closed -$992K

Similar funds

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
UM
Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
AI
Aperture Investors New York $791M AUM 54.66% 1-Year Est. Return

Johnson & Johnson's Q3 2024 Portfolio in Review

As of Q3 2024, Johnson & Johnson held 21 positions worth $427M, up 6.7% from $401M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Johnson & Johnson's Q3 2024 filing shows 1 new and 1 closed positions. Its largest new stake was Clearside Biomedical: 5,499 shares worth $105K. The largest sale was Aldeyra Therapeutics, an estimated $992K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Johnson & Johnson's largest Q3 2024 buy was Clearside Biomedical: 5,499 shares worth $105K.
  • Johnson & Johnson fully exited Aldeyra Therapeutics in Q3 2024, selling an estimated $992K.
  • Johnson & Johnson's ten largest holdings make up 94% of its $427M portfolio in Q3 2024.
  • Johnson & Johnson opened 1 new position and closed 1 in Q3 2024.
  • Johnson & Johnson's portfolio value rose 6.7% quarter-over-quarter to $427M.

Based on Johnson & Johnson's 13F filing for Q3 2024, filed 13 Nov 2024.